The estimated Net Worth of Holdings, Inc. Rafael is at least $4.3 Million dollars as of 1 August 2023. Holdings Rafael owns over 4,000,000 units of Cyclo Therapeutics stock worth over $4,299,880 and over the last few years Holdings sold CYTH stock worth over $0.
Holdings has made over 1 trades of the Cyclo Therapeutics stock since 2023, according to the Form 4 filled with the SEC. Most recently Holdings bought 4,000,000 units of CYTH stock worth $5,000,000 on 1 August 2023.
The largest trade Holdings's ever made was buying 4,000,000 units of Cyclo Therapeutics stock on 1 August 2023 worth over $5,000,000. On average, Holdings trades about 2,000,000 units every 0 days since 2023. As of 1 August 2023 Holdings still owns at least 6,514,970 units of Cyclo Therapeutics stock.
You can see the complete history of Holdings Rafael stock trades at the bottom of the page.
Holdings's mailing address filed with the SEC is 520, Broad Street, Newark, Essex County, New Jersey, 07114, United States.
Over the last 4 years, insiders at Cyclo Therapeutics have traded over $0 worth of Cyclo Therapeutics stock and bought 4,648,141 units worth $6,142,223 . The most active insiders traders include Holdings, Inc. Rafael, Shawn Cross, and N Scott Fine. On average, Cyclo Therapeutics executives and independent directors trade stock every 25 days with the average trade being worth of $78,661. The most recent stock trade was executed by Holdings, Inc. Rafael on 1 August 2023, trading 4,000,000 units of CYTH stock currently worth $5,000,000.
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Cyclo Therapeutics executives and other stock owners filed with the SEC include: